P-selectin glycoprotein ligand-1 may link early- and late-onset colorectal cancer pathways

◇ RESEARCH

A review proposes that PSGL-1, a molecule involved in chronic gut inflammation, may function as a molecular bridge between early-onset and late-onset colorectal cancer, offering insight into shared pathophysiological mechanisms. (Biomed Pharmacother)